España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ESSA Pharma
EPIX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.60
0.00
0.00%
At close: -
$1.61
0.01
0.63%
After Hours: Dec 20, 5:54 PM EDT
Get Report
Comment
Q4 2024 Earnings were released on Tue Dec 17th, before the market open
ESSA Pharma (EPIX) Forecast
News
Earnings
ESSA Pharma (EPIX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ESSA Pharma (NASDAQ:EPIX) Stock
ESSA Pharma Stock (NASDAQ: EPIX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
ESSA Pharma Q4 2024 GAAP EPS $(0.14) Beats $(...
Benzinga Newsdesk
Monday, November 04, 2024
ESSA Pharma shares are trading lower after Op...
Benzinga Newsdesk
Piper Sandler Downgrades ESSA Pharma to Neutr...
Benzinga Newsdesk
Oppenheimer Downgrades ESSA Pharma to Perform
Benzinga Newsdesk
Friday, November 01, 2024
Crude Oil Moves Higher; Apple Shares Slide After Q4 Results
Avi Kapoor
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
Avi Kapoor
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
Avi Kapoor
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
Vandana Singh
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Jones Trading Downgrades ESSA Pharma to Hold
Benzinga Newsdesk
ESSA Pharma shares are trading lower after th...
Benzinga Newsdesk
Reported Earlier, ESSA Pharma Terminates Phas...
Benzinga Newsdesk
Monday, September 16, 2024
ESSA Pharma shares are trading higher after t...
Benzinga Newsdesk
Prior Reported, ESSA Pharma Presents Data on ...
Benzinga Newsdesk
Thursday, May 16, 2024
Oppenheimer Maintains Outperform on ESSA Phar...
Benzinga Newsdesk
Tuesday, February 13, 2024
ESSA Pharma: Q1 Earnings Insights
Benzinga Insights
Tuesday, January 30, 2024
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
Benzinga Insights
Friday, January 26, 2024
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
Avi Kapoor
What's Going On With Prostate Cancer Focused ESSA Pharma Stock Today?
Vandana Singh
Thursday, January 25, 2024
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
ESSA Pharma Presents Updated Phase 1 Masofani...
Benzinga Newsdesk
Tuesday, January 16, 2024
Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
Avi Kapoor
Wednesday, December 13, 2023
Oppenheimer Reiterates Outperform on ESSA Pha...
Benzinga Newsdesk
Tuesday, December 12, 2023
ESSA Pharma Q4 EPS $(0.12) Up From $(0.14) Yo...
Benzinga Newsdesk
Recap: ESSA Pharma Q4 Earnings
Benzinga Insights
Monday, November 06, 2023
Essa Pharma Announced It May Offer And Sell Common Shares Having An Aggregate Offering Price Of Up To $50M From Time To Time Through Jefferies
Charles Gross
Saturday, October 21, 2023
ESSA Pharma Announced Data Combination Of Masofaniten Plus Enzalutamide Continues To Be Well Tolerated With Deep And Durable Reductions In PSA In Patients With Metastatic Castration-Resistant Prostate Cancer
Charles Gross
Monday, October 16, 2023
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, September 18, 2023
ESSA Pharma Announces Initiation Of Phase 2 S...
Benzinga Newsdesk
Monday, August 14, 2023
Watching ESSA Pharma; Zacks Small-Cap Research Sets $27 Price Valuation; Phase 2 Trial Of EPI-7386 in Combination With Enzalutamide To Initiate In Calendar 3Q23
Happy Mohamed
Wednesday, August 09, 2023
Oppenheimer Reiterates Outperform on ESSA Pha...
Benzinga Newsdesk
Monday, June 26, 2023
Oppenheimer Assumes ESSA Pharma at Outperform...
Benzinga Newsdesk
Thursday, May 18, 2023
Watching ESSA Pharma; Zacks Small-Cap Research Sets $27 Price Valuation; Says This Model Is Highly Dependent Upon Continued Clinical Success Of EPI-7386/TPD And Will Be Adjusted Accordingly Based Upon Future Clinical Results
Happy Mohamed
Tuesday, May 09, 2023
ESSA Pharma: Q2 Earnings Insights
Benzinga Insights
Wednesday, April 12, 2023
Essa Pharma Has Entered Into A Clinical Trial...
Benzinga Newsdesk
Monday, February 13, 2023
ESSA Pharma Announces Presentation At ASCO On...
Benzinga Newsdesk
Monday, December 19, 2022
Watching ESSA Pharma; Zacks Small-Cap Researc...
Benzinga Newsdesk
Tuesday, December 13, 2022
ESSA Pharma Q4 EPS $(0.14) Up From $(0.20) YoY
Bill Haddad
Monday, November 14, 2022
Watching ESSA Pharma; Zack's Small-Cap Resear...
Benzinga Newsdesk
Friday, November 11, 2022
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
Blue Star Foods
Tuesday, November 01, 2022
Ten Stocks Trending on Discord for Tuesday November 1, 2022: SOFI, SONN, AMZN, UBER, META, EPIX, NIO, UBX, VRNS, SFET
Charles Gross
'Essa Pharma Has Been Granted U.S. Patent Num...
Benzinga Newsdesk
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
Lisa Levin
Monday, October 31, 2022
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Ten Stocks Trending on Discord for Monday Oct...
Charles Gross
ESSA Pharma Shares Tank As Janssen Stops Enrollment In EPI-7386 Combo Prostate Cancer Trials
Vandana Singh
$8.2 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Lisa Levin
ESSA Pharma Shares Resume Trade Following Cir...
Benzinga Newsdesk
ESSA Pharma Shares Halted On Circuit Breaker ...
Benzinga Newsdesk
Show More